Jason Reber, Author at CathWorks FFRangio System

Don’t miss CathWorks at ACC.23/WCC March 4–6 in New Orleans!

FFRangio System
Clinical Studies
Resources
Company
Investors
Contact

CathWorks FFRangio® System: A New Era in Coronary Physiology
(TCT Boston 2022)

CathWorks Announces Key Events for TCT 2022

Medtronic Announces Co-Promotion Agreement With CathWorks, With Path Toward Acquisition

ACC 2022 – Guy Witberg, MD: Clinical Outcomes of Angiogram-Based FFR Guided Treatment for CAD

CRT 2022 – Live Case by Ascension St. John Hospital

Previous 1 2

Regulatory Status

The CathWorks FFRangio^® System has received United States 510(k) clearance, Israel Amar approval and Japan PMDA approval. The FFRangio System fulfills the requirements for CE marking (0344).

MAR-000590 Rev 10

CathWorks and FFRangio are registered trademarks of CathWorks

Privacy | Terms

MAR-000590 Rev 10

Contact CathWorks Today

* required fields

Interest Group*

Other Interests*

Organization*

Specialty*

Other Specialty*

Profession*

First Name*

Last Name*

Email*

Message

Opt-In

I would like to join the CathWorks mailing list for product and company updates

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.

CathWorks FFRangio® System: A New Era in Coronary Physiology(TCT Boston 2022)